3
Announcements
Trials
Browse
Landscape
Status
Completed
31
Terminated
5
Unknown
3
Withdrawn
2
Recruiting
2
Active not recruiting
1
Sponsor
Interventions
Cyclophosphamide
21
fludarabine
17
Specimen Handling
13
Magnetic Resonance Spectroscopy
10
pembrolizumab
9
Nivolumab
9
Radiotherapy
7
Cisplatin
7
fludarabine phosphate
5
Injections
5
tislelizumab
4
daratumumab
4
Rituximab
4
Paclitaxel
4
Ipilimumab
4
Interleukin-2
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Fluorouracil
4
Drug Therapy
4
Doxorubicin
4
Dexamethasone
4
Carboplatin
4
Biopsy
4
venetoclax
3
toripalimab
3
X-Rays
3
Radiosurgery
3
Platinum
3
Oxaliplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase 1
×
Not yet recruiting
×
Afatinib
×
Clear all
No trials found.